Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
Victoria Hall, Victor H. Ferreira, Matthew Ierullo, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3980-3989
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Queenie Fernandes, Varghese Inchakalody, Maysaloun Merhi, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 524-540
Open Access | Times Cited: 372
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 173
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses
Victoria Hall, Victor H. Ferreira, Heidi Wood, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 380-385
Open Access | Times Cited: 105
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 46
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Andrew H. Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 4, pp. 1253-1260
Open Access | Times Cited: 98
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 61
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 7, pp. 1873-1883
Open Access | Times Cited: 46
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls
Sebastian Rask Hamm, Dina Leth Møller, Laura Pérez‐Alós, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, et al.
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 890-911
Open Access | Times Cited: 37
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine
Deepali Kumar, Victor H. Ferreira, Victoria Hall, et al.
Annals of Internal Medicine (2021) Vol. 175, Iss. 2, pp. 226-233
Open Access | Times Cited: 48
Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
Muneyoshi Kimura, Victor H. Ferreira, Sagar Kothari, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 10, pp. 706.e1-706.e10
Open Access | Times Cited: 35
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients
Pierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 152-162
Open Access | Times Cited: 32
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis
Jiajing Li, Ibrahim Ayada, Yining Wang, et al.
Transplantation (2022) Vol. 106, Iss. 10, pp. 2068-2075
Open Access | Times Cited: 32
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients
Quentin Perrier, Julien Lupo, Théophile Gerster, et al.
Vaccine (2022) Vol. 40, Iss. 44, pp. 6404-6411
Open Access | Times Cited: 28
Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study
Victoria Hall, Ghadeer Al-Alahmadi, Javier T Solera, et al.
Transplantation (2022) Vol. 106, Iss. 8, pp. 1622-1628
Open Access | Times Cited: 27
Leukocyte Count in Solid Organ Transplant Recipients After SARS-CoV-2 mRNA Vaccination and Infection
Marita Kern, Sebastian Rask Hamm, Christian Ross Pedersen, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 103-103
Open Access
A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching
J. Lee, Jaiprasath Sachithanandham, John S. Lee, et al.
Microbiology Spectrum (2025)
Open Access
SARS-CoV-2 spike antibody levels in lung transplantation recipients versus the spectrum in non-immunocompromised persons
Michael Y. Shino, F. Javier Ibarrondo, Otto O. Yang
Vaccine (2025) Vol. 50, pp. 126851-126851
Closed Access
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital
Nicola Cotugno, Marco Sanna, Donato Amodio, et al.
Vaccine (2025) Vol. 49, pp. 126778-126778
Open Access
SARS‐CoV‐2‐Specific Antibodies in Pediatric Solid Organ Transplant Recipients: Benefits of Additional Vaccine Doses
Amanda L. Adler, Alpana Waghmare, Jodi M. Smith, et al.
Pediatric Transplantation (2025) Vol. 29, Iss. 2
Closed Access
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, et al.
Med (2021) Vol. 2, Iss. 12, pp. 1327-1341.e4
Open Access | Times Cited: 36
Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients
Lea Timmermann, Brigitta Globke, Georg Lurje, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1422-1422
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top